Pediyatrik Kalp Hastaliklarında Tanı Yöntemleri

Yazarlar

Fuat Laloğlu

Özet

Pediyatrik kardiyolojide tanı süreci; ayrıntılı hasta öyküsü, fizik muayene, göğüs radyografisi, nabız oksimetresi ve kan basıncı ölçümleri ile başlar. Öyküde gebelik, doğum, ilaç ve aile hikayesi detaylıca sorgulanırken; fizik muayenede siyanoz, üfürüm, periferik nabızlar, prekordiyum, organomegali ve döküntüler değerlendirilir. Göğüs röntgeni kardiyotorasik oran, kardiyak kontur ve pulmoner vaskülarite hakkında temel bilgiler sağlarken; nabız oksimetresi kritik siyanotik doğuştan kalp hastalıklarının erken yenidoğan döneminde taranmasında zorunlu bir kriterdir. Ekstremiteler arası kan basıncı ölçümü aort koarktasyonunu, 24 saatlik tansiyon Holter izlemi ise beyaz önlük hipertansiyonunu ve gece tansiyon yükünü tespit etmede kullanılır. Ritim ve iletim bozukluklarının tanısında elektrokardiyografi (EKG), 24 saatlik Holter EKG, anlık olay kaydediciler ve invaziv elektrofizyolojik çalışmalar kritik rol oynar. Ekokardiyografi (TTE, TÖE, Fetal ve Stres EKO); kalp odacıkları, kapaklar, kardiyak şantlar ve fonksiyonların değerlendirilmesinde ana noninvaziv görüntüleme yöntemidir. Egzersiz testi iskemi ve egzersiz kapasitesini, tilt table testi ise vazovagal senkopu değerlendirmede tercih edilir. Bilgisayarlı tomografi ve manyetik rezonans görüntüleme karmaşık anatomik ve vasküler anomalileri radyasyonsuz veya yüksek çözünürlüklü olarak sunarken, kardiyak kateterizasyon ve anjiyografi ayrıntılı hemodinamik veriler ve girişimsel tedavi imkanı sağlar. Ayrıca troponin, NT-proBNP ve CRP gibi spesifik biyokimyasal markerlar da tanı ve takip süreçlerini tamamlamaktadır.

Referanslar

Johnson WH, Moller JH (Eds.). (2014). Pediatric Cardiology: The Essential Pocket Guide (3rd ed.,pp.1-73). Hoboken: Wiley-Blackwell.

Cassidy SC, Allen HD, Phillips JR. (2016). History and Physical Examination. Hugh D. Allen, Robert E. Shaddy, Daniel J. Penny,Timothy F. Feltes, Frank Cetta (Eds.), Moss & Adams' Heart Disease in Infants, Children, and Adolescents, Including the Fetus and Young Adult (pp. 250-261).China:Lippincott Williams & Wilkins.

Ertuğrul İ, Özkutlu S.(2017). Kalp Hastalıklarında Tanı. Murat Yurdakök (Ed.). Yurdakök Pediatri (s.2975-2980). Ankara: Güneş Tıp Kitapevleri.

Ertuğrul T, Ömeroğlu RE, Dindar A, Aydoğan Ü, Nişli K. (2010). Kalp-Damar Sisteminin Değerlendirilmesi. Olcay Neyzi, Türkan Ertuğrul (Eds.), Pediyatri (s.1131-1155). İstanbul: Nobel Tıp Kitabevleri.

Park MK. (2014). Park's Pediatric Cardiology for Practitioners. (pp.314-318). Philadelphia: Elsevier Saunders.

Ahmad H, Chowdhury D.(2018). Neonatal Screening for Heart Disease. Jonathan N. Johnson, Deepak M. Kamat (Eds.), Common Cardiac Issues in Pediatrics (pp. 197-204). USA: American Academy of Pediatrics.

Martin GR, Ewer AK, Gaviglio A, et al. Updated Strategies for Pulse Oximetry Screening for Critical Congenital Heart Disease. Pediatrics. 2020 Jul;146(1):e20191650. doi: 10.1542/peds.2019-1650.

Kemper AR, Mahle WT, Martin GR, et al. Strategies for implementing screening for critical congenital heart disease. Pediatrics. 2011;128(5):e1259–e1267.

Hsu DT, Gersony WM. (2014). Assessment of the Cardiac Patient: History and Physical Examination. Eduardo da Cruz, Dunbar Ivy, James Jaggers (Eds.), Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care (pp.303-315). London: Springer.

Park MK. (2014). Park's Pediatric Cardiology for Practitioners. (pp.184-205). Philadelphia: Elsevier Saunders.

Park MK. (2014). Park's Pediatric Cardiology for Practitioners. (pp.77-116). Philadelphia: Elsevier Saunders.

Ali US, Ohri A. (2013). Systemic Hypertension in Children. Kumar RK, Prabhu SS, Ahamed MZ (Eds.). Pediatric Cardiology (IAP Speciality Series) (pp. 95-108).India: Jaypee Brothers Medical Publishers.

Park M, Guntheroth W. (2006).How to Read Pediatric ECGs. (4th ed.). USA: Mosby.

Van Hare GF, Silva JNA. (2016). The Normal Electrocardiogram. Hugh D. Allen, Robert E. Shaddy, Daniel J. Penny,Timothy F. Feltes, Frank Cetta (Eds.), Moss & Adams' Heart Disease in Infants, Children, and Adolescents, Including the Fetus and Young Adult (pp. 548-565).China:Lippincott Williams & Wilkins.

Fogoros RN. (2006). Electrophysiologic Testing (4th Ed.). USA: Wiley-Blackwell.

de Bakker JMT, Vos MA. (2012). Methodological and Technical Considerations. Shenasa M, Hindricks G, Borggrefe M, Breithardt G, Josephson ME (Eds.). Cardiac Mapping (pp. 3-11). UK: Wiley-Blackwell.

Kelle AM, Qureshi MY. (2018). The Role of Echocardiography. Jonathan N. Johnson, Deepak M. Kamat (Eds.), Common Cardiac Issues in Pediatrics (pp. 49-70). USA: American Academy of Pediatrics.

Ayabakan C. (2017). Ekokardiyografi. Murat Yurdakök (Ed.). Yurdakök Pediatri (s.2992-3002). Ankara: Güneş Tıp Kitapevleri.

Miller OI, Bell AJ, Simpson JM. (2016). Transesophageal and Intraoperative Echocardiography. Lai WW, Mertens LL, Cohen MS, Geva T (Eds.), Echocardiography in Pediatric and Congenital Heart Disease: From Fetus to Adult (pp.777-790). UK: Wiley-Blackwell.

Johnson WH, Moller JH (Eds.). (2014). Pediatric Cardiology: The Essential Pocket Guide (pp.1-72). Hoboken: Wiley-Blackwell.

Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. American Heart Association Adults With Congenital Heart Disease Joint Committee of the Council on Cardiovascular Disease in the Young and Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Council on Cardiovascular and Stroke Nursing. Diagnosis and treatment of fetal cardiac disease: A scientific statement from the American Heart Association. Circulation. 2014;129:2183–2242.

Araujo JJ. Stress Echocardiography in Pediatric and Adult Congenital Heart Disease: A Complement in Anatomical and Functional Assessment. Curr Probl Cardiol. 2021 Mar;46(3):100762. doi: 10.1016/j.cpcardiol.2020.100762.

Ciliberti P, McLeod I, Cairello F, et al. Semi-supine exercise stress echocardiography in children and adolescents: feasibility and safety. Pediatr Cardiol. 2015 Mar;36(3):633-9. doi: 10.1007/s00246-014-1058-4.

Morrical B, Johnson JN. (2018). Basics of Exercise Testing. Jonathan N. Johnson, Deepak M. Kamat (Eds.), Common Cardiac Issues in Pediatrics (pp. 71-78). USA: American Academy of Pediatrics.

Park MK. (2014). Park's Pediatric Cardiology for Practitioners. (pp.505-515). Philadelphia: Elsevier Saunders.

Bernstein D. (2020). Laboratory Cardiac Evaluation. Robert M. Kliegman, Joseph W. St. Geme (Eds.), Nelson Textbook of Pediatrics (pp. 2354-2367). Kanada: Elsevier.

Krishnamurthy R, Golriz F, Jadhav S. (2016). Cardiac Computed Tomography in Children with Congenital Heart Disease. Hugh D. Allen, Robert E. Shaddy, Daniel J. Penny,Timothy F. Feltes, Frank Cetta (Eds.), Moss & Adams' Heart Disease in Infants, Children, and Adolescents, Including the Fetus and Young Adult (pp. 413-437).China:Lippincott Williams & Wilkins.

Meadows AK, Dae MW. (2011). Radiologic Imaging. Rudolph CD, Rudolph AM, Lister GE, First L, Gershon AA. (Eds.), Rudolph's Pediatrics (pp.1873-1887 ). USA: McGraw-Hill Education.

Geva T, Powell AJ. (2016). Magnetic Resonance Imaging. Hugh D. Allen, Robert E. Shaddy, Daniel J. Penny,Timothy F. Feltes, Frank Cetta (Eds.), Moss & Adams' Heart Disease in Infants, Children, and Adolescents, Including the Fetus and Young Adult (pp. 374-413).China:Lippincott Williams & Wilkins.

Mc Mahon CJ, Eidem BW, Bezold LI, et al. Is cardiac catheterization a prerequisite in all patients undergoing bidirectional cavopulmonary anastomosis? J Am Soc Echocardiogr. 2003 Oct;16(10):1068-72. doi: 10.1016/S0894-7317(03)00592-3.

Ro PS, Rychik J, Cohen MS, et al. Diagnostic assessment before Fontan operation in patients with bidirectional cavopulmonary anastomosis: are noninvasive methods sufficient? J Am Coll Cardiol. 2004 Jul 7;44(1):184-7. doi: 10.1016/j.jacc.2004.02.058.

Sun RR, Lu L, Liu M, et al. Biomarkers and heart disease. Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2927-35.

Hauser JA, Demyanets S, Rusai K, et aI. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure. Heart. 2016 Oct 15;102(20):1633-9. doi: 10.1136/heartjnl-2016-309460.

Piek A, Du W, de Boer RA, et al. Novel heart failure biomarkers: why do we fail to exploit their potential? Crit Rev Clin Lab Sci. 2018 Jun;55(4):246-263. doi: 10.1080/10408363.2018.1460576.

Gelecek

17 Mayıs 2021

Lisans

Lisans